Novel Coronavirus (SARS-CoV-2/COVID-19)
For nearly 20 grueling months, hospitals and health systems – and their steadfast front-line caregivers – have risen to the incredible challenges caused by COVID-19.
The Centers for Disease Control and Prevention revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna’s vaccine deemed most effective at preventing hospitalizations.
The Centers for Disease Control and Prevention will invest $2.1 billion from the American Rescue Plan Act to help public health and other partners fight COVID-19 and other emerging infections in health care facilities, the Biden Administration announced.
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19 vaccine confidence in the hospital field, clinicians and the public.
A pair of peer-reviewed studies published in the New England Journal of Medicine are affirming the safety and effectiveness of Pfizer’s COVID-19 vaccine, first at six months following a completed, two-dose regimen, and then with boosters.
The Food and Drug Administration released updated enforcement policy related to face masks, barrier face coverings, face shields, surgical masks and respirators for the duration of the COVID-19 public health emergency.
The AHA released a new issue of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The AHA Sept. 17 at 10 a.m. ET is hosting a webinar with HCA Healthcare leaders Edmund Jackson, M.D., and Jeffrey Guy, M.D., who will share oxygen conservation strategies as COVID-19 cases surge nationwide, leading to limitation in supplies.
On this episode, Dr. Hochman discusses the COVID-19 pandemic and public health infrastructure with Mike Slubowski, president and CEO at Trinity Health, a Catholic health system that serves communities in 25 states.
The National Institutes of Health awarded about $470 million from the American Rescue Plan Act to New York University Langone Health for a project to study the long-term effects of COVID-19.